Clinical Trials | December 28, 2021
RaphaCure partners with Zeebon for foraying into North East market
Zeebon is the largest diagnostics services provider in North-Eastern states
Zeebon is the largest diagnostics services provider in North-Eastern states
The product is expected to be available in a week’s time
It plans to deliver over 300 million doses to the Indian government
The drug will be marketed under the brand name Molnaflu
The single-dose vaccine has been approved in China, Mexico, Ecuador, Chile, Argentina, Hungary, Kirghizstan, Pakistan, Indonesia and Malaysia
After specialising in laparoscopy, proctology, urology, and cosmetic surgeries, Glamyo Health is now venturing into orthopaedic surgeries
FDA changes inspection classification of the facility to Voluntary Action Indicated
Scoliosis is a disorder of the spine, and its surgeries are generally done only in large hospitals in big cities.
Under this scheme, the company will make a committed investment in plant and machinery, get incentives on incremental sales of pharmaceutical products
Approvals accorded under Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ drug intermediates and Active Pharmaceutical Ingredients (APIs
Subscribe To Our Newsletter & Stay Updated
